Gossamer Bio, Inc. (GOSS) 8-K Current Report — March 17, 2026
Filed: March 17, 2026
Health Care
Pharmaceutical PreparationsGossamer Bio, Inc. (GOSS) 8-K current report filed with SEC EDGAR on March 17, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 2.02: Results of Operations and Financial Condition
Gossamer Bio, Inc. 8-K Mar 17, 2026 Event Analysis
Item 2.02 · Results of Operations and Financial Condition
- • Q4 and full-year FY2025 financial results reported March 17, 2026
- • Full results in Exhibit 99.1 press release — primary source for revenue, cash, and pipeline spend figures
Other Gossamer Bio, Inc. 8-K Filings
Get deeper insights on Gossamer Bio, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.